Dr. Shellee Layne Kaipoi Ogawa, MD

Dr. Ogawa practices at Mercy Hospital St Louis - Oncology and Hematology Patients First - HOPD in Washington, Missouri.

Dr. Ogawa's NPI, 1659722403, was assigned on June 23, 2016. Dr. Ogawa holds Missouri license 2021017796.

Dr. Ogawa's primary practice is Mercy Hospital St Louis - Oncology and Hematology Patients First - HOPD, at 901 Patients First Dr, Washington, MO 63090.

Dr. Ogawa's primary practice is Mercy Hospital St Louis - Oncology and Hematology Patients First - HOPD in Washington, Missouri. Dr. Ogawa is also affiliated with Mercy Hospital St. Louis. The medical group on file is Mercy Clinic Urology - Patients First Drive. Dmand AI also links Dr. Ogawa to 2 more hospitals, 1 group practice or clinic and 1 hospital outpatient department, each named with a free account. Dr. Ogawa's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Ogawa practices, 6 sites in all. Vendor and product names are available with a free account.

Urology is Dr. Ogawa's primary specialty in the NPI Registry, under taxonomy code 208800000X. Dr. Ogawa is licensed in Missouri.

CMS data shows 436 Medicare services from Dr. Ogawa across 8 procedure codes in 2024, for 170 Medicare patients. Medicare paid $38,021 for them.

CMS counts 170 Medicare patients who saw Dr. Ogawa in 2024. The largest group is 75 to 84, with 68 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 14% are also on Medicaid. Their average risk score is 1.74, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Ogawa's median patient age at 69, with 48% women.

In 2024, Dr. Ogawa wrote 777 Medicare Part D claims for 211 patients. 79% of them were for generic drugs. CMS names the drug for 694 of them, across 17 drugs with 11 or more claims each, at $77,824 in total drug cost. In 2023, CMS named 440 claims across 13 drugs.

Dr. Ogawa accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Ogawa as offering telehealth.

Prostate resection: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 7 papers to Dr. Ogawa, published from 2018 to 2025. 2018 was the busiest year, with 2. The most frequent topics are Hand Strength and Patient Satisfaction. Dr. Ogawa has published most often in Urology. Dr. Ogawa's most frequent co-authors are Wesley Richard Baas, MD, Joseph Baiocco, MD and Alexander Chow, MD.

CMS Open Payments shows 191 general payments to Dr. Ogawa from 34 drug and device companies from 2017 to 2025. Food and beverage make up the largest share, 69% of the total. Boston Scientific Corporation paid the most, $2,854.